Pneumothorax Treatment Devices Market Report 2025

This Pneumothorax Treatment Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The pneumothorax treatment devices market size has grown rapidly in recent years. It will grow from $3.62 billion in 2024 to $4.01 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the increasing incidence of pneumothorax, growing awareness about the condition, the expansion of emergency and trauma care facilities, an aging population, and a rise in surgical procedures.

The pneumothorax treatment devices market size is expected to see rapid growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period is expected to be driven by the increasing prevalence of respiratory diseases, a higher number of thoracic surgeries, greater investment in healthcare infrastructure, enhanced diagnostic capabilities, and a stronger focus on preventative healthcare. Key trends in this period include technological advancements in medical devices, the development of advanced chest drainage systems, the use of automated thoracic catheters, progress in minimally invasive procedures, and the integration of telemedicine.

The increasing prevalence of respiratory diseases is expected to drive the growth of the pneumothorax treatment devices market. Respiratory diseases are conditions that affect the lungs and airways, leading to impaired breathing and oxygen exchange. The rise in respiratory diseases can be attributed to factors such as air pollution, smoking, viral infections, and greater exposure to allergens. Pneumothorax treatment devices are crucial in managing collapsed lungs and restoring normal breathing. For example, in June 2024, the American Lung Association, a US-based non-profit organization, reported that in 2022, around 44.2 million Americans, or 13.5% of the population, had been diagnosed with asthma by a qualified healthcare professional. This increasing incidence of respiratory diseases is driving the growth of the pneumothorax treatment devices market.

Leading companies in the pneumothorax treatment devices market are focusing on developing advanced technological solutions, such as chest X-ray systems, to maintain their market position. Chest X-ray solutions involve imaging systems and technologies designed to capture detailed radiographic images of the chest, including the lungs, heart, ribs, and surrounding structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced that it received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to aid in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-powered software enhances care in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare providers. The qXR-PTX-PE solution analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings, where these conditions can pose serious risks to patient health.

In January 2022, ICU Medical, a US-based medical technology company, acquired Smiths Medical from Smiths Group plc for $2.4 billion. This acquisition is strategically aligned with ICU Medical's long-term growth and innovation objectives within the medical device industry. Smiths Medical, a US-based company, specializes in providing chest drainage devices, including the Portex ambulatory chest drainage system.

Major players in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., and Selio Medical Inc.

North America was the largest region in the pneumothorax treatment devices market in 2024. The regions covered in pneumothorax treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pneumothorax treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pneumothorax treatment devices are medical tools used to manage and treat a collapsed lung, a condition in which air accumulates in the pleural space. These devices aim to remove excess air, restore lung expansion, and prevent further complications, often through methods such as needle decompression or chest tube insertion.

The primary types of pneumothorax treatment devices include ventilator devices, thoracic vent devices, and others. Ventilator devices used in pneumothorax treatment help assist or control breathing by delivering air to the lungs, thereby maintaining oxygen levels and preventing further lung collapse during recovery. These devices are employed in various situations, such as traumatic pneumothorax, spontaneous pneumothorax, and others, in settings such as hospitals, ambulatory surgical centers, and other medical facilities.

The pneumothorax treatment devices market research report is one of a series of new reports that provides pneumothorax treatment devices market statistics, including the pneumothorax treatment devices industry global market size, regional shares, competitors with the pneumothorax treatment devices market share, detailed pneumothorax treatment devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pneumothorax treatment devices industry. This pneumothorax treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pneumothorax treatment devices market consists of sales of products including tubes, valves, suction devices and systems, and digital thoracic drainage systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.